Rapamycin is an effective inhibitor of human renal cancer metastasis11See Editorial by Sukhatme and Strom, p. 1160.
- 1 March 2003
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 63 (3), 917-926
- https://doi.org/10.1046/j.1523-1755.2003.00805.x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases developmentJCI Insight, 1999
- Renal Cell Carcinoma of Native Kidneys: Prospective Study of 129 Renal Transplant PatientsJournal of Urology, 1997
- Vascular Endothelial Growth Factor Expression is Increased in Renal Cell CarcinomaJournal of Urology, 1997
- Renal Cell Carcinoma Metastatic to the Lung: Potential Benefit in the Combination of Biological Therapy and SurgeryJournal of Urology, 1996
- Tumour suppression by the human von Hippel-Lindau gene productNature Medicine, 1995
- PRIMARY KIDNEY TUMORS BEFORE AND AFTER RENAL TRANSPLANTATION1,2Transplantation, 1995
- Renal cell carcinoma in patients withend-stage renal disease: A comparison of clinical significance in patients receiving hemodialysis and those with renal transplantsUrology, 1994
- Cancer statistics, 1994CA: A Cancer Journal for Clinicians, 1994
- Activity of rapamycin (AY-22,989) against transplanted tumors.The Journal of Antibiotics, 1984
- New antitumor substances of natural originCancer Treatment Reviews, 1981